Profilo
William H.
Collier currently works at Genevant Sciences Corp., as Director.
Mr. Collier also formerly worked at Arbutus Biopharma Corp., as President, Chief Executive Officer & Director from 2019 to 2023, Arbutus Biopharma, Inc., as President & Chief Executive Officer, International Partnership for Microbicides, as Director from 2018 to 2021, Glaxowellcom, as Area Director, Aids United, as Director from 2011 to 2018, and ViiV Healthcare Ltd., as President & GM-North America Region.
Mr. Collier received his undergraduate degree from the University of Manchester Institute of Science & Technology.
Posizioni attive di William Collier
| Società | Posizione | Inizio |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di William Collier
| Società | Posizione | Fine |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Amministratore Delegato | 31/12/2023 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Amministratore Delegato | 31/12/2023 |
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Direttore/Membro del Consiglio | 01/01/2021 |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Direttore/Membro del Consiglio | 01/01/2018 |
Glaxowellcom | Corporate Officer/Principal | - |
Formazione di William Collier
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Health Technology |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxowellcom | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Commercial Services |
















